WISeSAT.Space, a WISeKey Subsidiary, Strengthens Its Strategic Partnership with Swiss Armed Forces in the Space Sector for 2024 and Beyond; Plans Include the Launch of an Enhanced WISeSat Satellite in Q3 2024 Using SpaceX
April 29, 2024 01:00 ET
|
Wisekey International Holding Ltd.
Geneva and Bern, Switzerland, April 29, 2024 (GLOBE NEWSWIRE) -- WISeSAT.Space, a subsidiary of WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in...
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
April 29, 2024 01:00 ET
|
Addex Therapeutics
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...
EPH European Property Holdings PLC announces 2023 Year-End Result
April 26, 2024 17:55 ET
|
EPH European Property Holdings PLC
26 April 2024, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR BUSINESS HIGHLIGHTS 2023 Despite the challenging market environment, EPH European Property Holdings PLC...
Ehdotukset Kuntarahoituksen varsinaiselle yhtiökokoukselle
April 26, 2024 04:00 ET
|
Kuntarahoitus Oyj
Kuntarahoitus OyjPörssitiedote26.4.2024 klo 11.00 Ehdotukset Kuntarahoituksen varsinaiselle yhtiökokoukselle Kuntarahoitus Oyj:n (Kuntarahoitus) hallitus ja omistajien nimitysvaliokunta ovat tehneet...
Proposals to the Annual General Meeting of Municipality Finance Plc
April 26, 2024 04:00 ET
|
Municipality Finance Plc
Municipality Finance PlcStock Exchange Release 26 April 2024 at 11:00 am (EEST) Proposals to the Annual General Meeting of Municipality Finance Plc Municipality Finance Plc’s (hereinafter MuniFin)...
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
April 26, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin...
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
April 26, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin...
ArcelorMittal S.A.: ArcelorMittal announces the publication of its first quarter 2024 sell-side analyst consensus figures
April 25, 2024 08:27 ET
|
ArcelorMittal S.A.
25 April 2024, 14:30 CET ArcelorMittal (‘the Company’) today announces the publication of its first quarter 2024 sell-side analyst consensus figures. The consensus figures are based on...
Kuntarahoitus laskee liikkeeseen 50 miljoonan Englannin punnan lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa
April 25, 2024 03:00 ET
|
Kuntarahoitus Oyj
Kuntarahoitus OyjPörssitiedote25.04.2024 klo 10.00 Kuntarahoitus laskee liikkeeseen 50 miljoonan Englannin punnan lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee...
Municipality Finance issues a GBP 50 million tap under its MTN programme
April 25, 2024 03:00 ET
|
Municipality Finance Plc
Municipality Finance PlcStock exchange release 25 April 2024 at 10:00 am (EEST) Municipality Finance issues a GBP 50 million tap under its MTN programme On 26 April 2024 Municipality Finance Plc...